Seattle-based Navigating Cancer, a provider of oncology patient relationship management solutions, has secured $26 million in Series D funding. Merck Global Health Innovation Fund and TT Capital Partners led the round with participation from other investors that included American Cancer Society's new philanthropic venture fund BrightEdge, LabCorp, ORIX Growth Capital and Rustic Canyon Partners.
Thoma Bravo, Vista back identity security assets; Hospital hacks spur add-on for Altaris-backed Tegria
6 November 2026 · 4 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
6 November 2026 · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
6 November 2026 · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
6 November 2026 · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 November 2026 · 3 mins read
LDC backs London management consultancy Moorhouse after sale by Expleo
6 November 2026 · 2 mins read
PAI and ICG receive VKR Holding offer for window shutter maker StellaGroup
6 November 2026 · 2 mins read
